Chapter 18
Bioengineered Scaffolds: Myocytes, Endothelial Cells and Cardiac Repair
Vincent F.M. Segers MD,
Richard T. Lee MD,
Vincent F.M. Segers MD
Search for more papers by this authorRichard T. Lee MD
Search for more papers by this authorVincent F.M. Segers MD,
Richard T. Lee MD,
Vincent F.M. Segers MD
Search for more papers by this authorRichard T. Lee MD
Search for more papers by this authorBook Editor(s):Annarosa Leri MD,
Piero Anversa MD,
William H. Frishman MD,
Annarosa Leri MD
Professor of Medicine, Department of Medicine, Cardiovascular Research Institute, New York Medical College, Valhalla, NY
Search for more papers by this authorPiero Anversa MD
Professor of Medicine and Vice Chairman, Department of Medicine, Director, Cardiovascular Research Institute, New York Medical College, Valhalla, NY
Search for more papers by this authorWilliam H. Frishman MD
Rosenthal Professor and Chairman, Department of Medicine, New York Medical College, Director of Medicine, Westchester Medical Center, Valhalla, NY
Search for more papers by this authorFirst published: 01 January 2007
Summary
This chapter contains sections titled:
-
Introduction
-
Importance of endothelial cells and fibroblasts for preservation of implanted cells
-
In vitro creation of cardiac tissue
-
Injectable biomaterials
-
Key factors in material selection
-
Smart biomaterials
-
Conclusions
References
- Itescu S, Schuster MD, Kocher AA. New directions in strategies using cell therapy for heart disease. J Mol Med 2003; 81: 288–296.
- Dowell JD, Rubart M, Pasumarthi KB, et al. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 2003; 58: 336–350.
- Williams DF. To engineer is to create: the link between engineering and regeneration. Trends Biotechnol 2006; 24: 4–8.
- Brutsaert DL. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 2003; 83: 59–115.
- Narmoneva DA, Oni O, Sieminski AL, et al. Self-assembling short oligopeptides and the promotion of angiogenesis. Biomaterials 2005; 26: 4837–4846.
- Davis ME, Motion JP, Narmoneva DA, et al. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 2005; 111: 442–450.
- Kedem A, Perets A, Gamlieli-Bonshtein I, et al. Vascular endothelial growth factor-releasing scaffolds enhance vascularization and engraftment of hepatocytes transplanted on liver lobes. Tissue Eng 2005; 11: 715–722.
- Perets A, Baruch Y, Weisbuch F, et al. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A 2003; 65: 489–497.
- Eschenhagen T, Zimmermann WH. Engineering myocardial tissue. Circ Res 2005; 97: 1220–1231.
- Narmoneva DA, Vukmirovic R, Davis ME, et al. Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration. Circulation 2004; 110: 962–968.
- Hsieh PC, Davis ME, Gannon J, et al. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest 2006; 116: 237–248.
- Kuramochi Y, Cote GM, Guo X, et al. Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1beta/erbB4 signaling. J Biol Chem 2004; 279: 51141–51147.
- Camelliti P, Borg TK, Kohl P. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res 2005; 65: 40–51.
- Fink C, Ergun S, Kralisch D, et al. Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J 2000; 14: 669–679.
- Christman KL, Vardanian AJ, Fang Q, et al. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 2004; 44: 654–660.
- Ryu JH, Kim IK, Cho SW, et al. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials 2005; 26: 319–326. CHAPTER 18 Bioengineered scaffolds 191
- Kofidis T, de Bruin JL, Hoyt G, et al. Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. J Thorac Cardiovasc Surg 2004; 128: 571–578.
- Zhang S, Gelain F, Zhao X. Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures. Semin Cancer Biol 2005; 15: 413–420.
- Dar A, Shachar M, Leor J, Cohen S. Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biotechnol Bioeng 2002; 80: 305–312.
- Ito H, Steplewski A, Alabyeva T, Fertala A. Testing the utility of rationally engineered recombinant collagen-like proteins for applications in tissue engineering. J Biomed Mater Res A 2006; 76: 551–560.
-
Cannizzaro SM,
Padera RF,
Langer R, et al.
A novel biotinylated degradable polymer for cell-interactive applications.
Biotechnol Bioeng
1998;
58:
529–535.
10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.0.CO;2-F CAS PubMed Web of Science® Google Scholar
- Lee KY, Alsberg E, Hsiong S, et al. Nanoscale adhesion ligand organization regulates osteoblast proliferation and differentiation. Nano Lett 2004; 4: 1501–1506.
- Mwale F, Wang HT, Nelea V, et al. The effect of glow discharge plasma surface modification of polymers on the osteogenic differentiation of committed human mesenchymal stem cells. Biomaterials 2006; 27: 2258–2264.
- Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005; 26: 5474–5491.
- Karande TS, Ong JL, Agrawal CM. Diffusion in musculoskeletal tissue engineering scaffolds: design issues related to porosity, permeability, architecture, and nutrient mixing. Ann Biomed Eng 2004; 32: 1728–1743.
- Ozawa CR, Banfi A, Glazer NL, et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 2004; 113: 516–527.
- Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362: 697–703.
- Chau Y, Tan FE, Langer R. Synthesis and characterization of dextran-peptide-methotrexate conjugates for tumor targeting via mediation by matrix metalloproteinase II and matrix metalloproteinase IX. Bioconjug Chem 2004; 15: 931–941.
- Behfar A, Terzic A. Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny. Nat Clin Pract Cardiovasc Med 2006; 3 (suppl 1): S78–S82.
- Fairman R, Akerfeldt KS. Peptides as novel smart materials. Curr Opin Struct Biol 2005; 15: 453–463.
